IP Library › Assignment 020426/0703
Patent Assignment
Reel/Frame 020426/0703

Assignment of Assignor's Interest

Recorded: 2008-01-16 Pages: 3
Assignor
AMGEN INC.
Executed: 2008-01-16
Assignee
MEDAREX, INC.
707 STATE ROAD, SUITE 206, PRINCETON, NEW JERSEY, 08540
Covered Property (1)
Human Anti-Opgl Neutralizing Antibodies as Selective Opgl Pathway Inhibitors
Patent: 7,718,776 →
Application: 10/408,901 →
Publication: US 2004/0023313
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 3, 2003
From: BOYLE, WILLIAM J.; MEDLOCK, EUGENE; SULLIVAN, JOHN K.; ELLIOTT, ROBIN L.
To: AMGEN INC.
Reel/Frame 014549/0060 →
Corrective Assignment to Correct the Nature of Conveyance Previously Recorded on Reel 020426 Frame 0703. Assignor(S) Hereby Confirms the Nature of Conveyance Is Assignment of Equal, Undivided Interest. Mar 11, 2008
From: AMGEN INC.
To: MEDAREX, INC.
Reel/Frame 020634/0257 →
Merger Aug 15, 2013
From: MEDAREX, INC.
To: MEDAREX, L.L.C.
Reel/Frame 031016/0678 →
Merger Jun 2, 2015
From: MEDAREX, L.L.C.
To: E. R. SQUIBB & SONS, L.L.C.
Reel/Frame 035767/0494 →